MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.732
-0.006 (-0.77%)
Dec 3, 2024, 11:22 AM EST - Market open
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $28.95 million as of December 3, 2024. Its market cap has decreased by -15.05% in one year.
Market Cap
28.95M
Enterprise Value
27.23M
1-Year Change
-15.05%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $28.95M, a decrease of -92.51%. That is a compound annual growth rate of -56.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 28.95M | -21.62% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allurion Technologies | 29.98M |
| Akari Therapeutics, | 29.96M |
| Daré Bioscience | 29.80M |
| IRIDEX | 29.78M |
| CERo Therapeutics Holdings | 29.01M |
| IGC Pharma | 28.89M |
| Co-Diagnostics | 28.44M |
| DURECT | 27.32M |